Gerold Schmitt-Ulms

Application of CRISPR genetic screens to investigate neurological diseases

Raphaella W. L. So, Sai Wai Chung, Heather H. C. Lau, 2019, Molecular Neurodegeneration.

An updated h-index measures both the primary and total scientific output of a researcher

Roman A. Zubarev, George A. Calin, Feng Yang, 2015, Discoveries.

Mass Spectrometric Analysis of Protein Mixtures at Low Levels Using Cleavable 13C-Isotope-coded Affinity Tag and Multidimensional Chromatography*

Robert J Chalkley, Jan Hirsch, Kirk C Hansen, 2003, Molecular & Cellular Proteomics.

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining

Gerold Schmitt-Ulms, Christine Sato, Ekaterina Rogaeva, 2016, PloS one.

Both the Sequence and Length of the C Terminus of PEN-2 Are Critical for Intermolecular Interactions and Function of Presenilin Complexes*

Hiroshi Hasegawa, Paul M. Mathews, Gerold Schmitt-Ulms, 2004, Journal of Biological Chemistry.

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

Pauline M. Rudd, Giuseppe Legname, Stanley B. Prusiner, 2001, Nature.

The CNS glycoprotein Shadoo has PrPC-like protective properties and displays reduced levels in prion infections

Bob Strome, Gerold Schmitt-Ulms, Patrick Horne, 2007, The EMBO journal.

Proteome-wide identification of mycobacterial pupylation targets

Kai Stühler, Matthias Wilmanns, Gerold Schmitt-Ulms, 2010, Molecular systems biology.

Overcoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn

Gerold Schmitt-Ulms, Hansen Wang, Carl He Ren, 2013, Molecular Neurodegeneration.